Work

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously-Treated Patients with Hemophilia B: Results from an Extension Trial

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.2846.2846

Authors: Guy Young, Peter W. Collins, Ramin Tehranchi, Ampaiwan Chuansumrit, Hideji Hanabusa, Steven R. Lentz, Johnny N. Mahlangu, Evelien Mauser-Bunschoten, Claude Negrier, Johannes Oldenburg, Turkan Patiroglu, Elena Santagostino, Marek Zak, Fara Abdul Karim

Institutions: University of Southern California, Children's Hospital Los Angeles, Cardiff University, Novo Nordisk (Denmark), Mahidol University, Ramathibodi Hospital, Ogikubo Hospital, University of Iowa, National Health Laboratory Service, University of the Witwatersrand, University Medical Center Utrecht, Lyon 1 Université, Hôpital Edouard Herriot, University of Bonn, Erciyes University, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2559999763

FWCI: 0.445

Cites:

Cited by: 3

Related to: 10